Patient Safety and Drug Labeling Improvement Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Patient Safety and Drug Labeling Improvement Act - Amends the Federal Food, Drug, and Cosmetic Act to allow the holder of an approved abbreviated new drug application (generic drug approval) to change the labeling of a drug so approved in the same manner authorized by regulation for the holder of an approved new drug application.
Allows conforming changes to be ordered to the labeling of the equivalent listed drug and each drug approved under the abbreviated new drug application process that corresponds to such listed drug.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4384: Patient Safety and Drug Labeling Improvement Act. 112th Congress. Open America. https://openamerica.io/bill/112-HR-4384/
"H.R. 4384: Patient Safety and Drug Labeling Improvement Act." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HR-4384/.
H.R. 4384, 112th Cong. (2026), https://openamerica.io/bill/112-HR-4384/.
[H.R. 4384: Patient Safety and Drug Labeling Improvement Act](https://openamerica.io/bill/112-HR-4384/)